Financial Ratios

AMERISE BIOSCIENCES LTD.

NSE : NABSE : 531681ISIN CODE : INE673C01020Industry : Finance - InvestmentHouse : Private
BSE0.82-0.03 (-3.53 %)
PREV CLOSE ( ) 0.85
OPEN PRICE ( ) 0.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 103722
TODAY'S LOW / HIGH ( )0.82 0.85
52 WK LOW / HIGH ( ) 0.51.03
NSE
This Company is not listed in NSE
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)0.00-0.02-0.020.08-0.05
   CEPS(Rs)0.00-0.02-0.020.08-0.05
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.810.810.840.850.77
   Tax Rate(%)25.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-0.22
   EBIT Margin(%)6.10
   Pre Tax Margin(%)6.10
   PAT Margin (%)6.10
   Cash Profit Margin (%)6.10
Performance Ratios
   ROA(%)0.08-2.65-1.356.24-5.79
   ROE(%)0.11-2.68-2.1310.24-6.41
   ROCE(%)0.15-2.65-2.1010.17-6.41
   Asset Turnover(x)0.000.000.001.020.00
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)0.000.000.00-242.150.00
Efficiency Ratios
   Fixed Capital/Sales(x)0.00
   Receivable days251.89
   Inventory Days0.00
   Payable days138.11
Valuation Parameters
   PER(x)1011.110.000.0016.370.00
   PCE(x)1054.79-29.85-38.9016.36-32.34
   Price/Book(x)1.120.810.841.592.14
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.01
   EV/Core EBITDA(x)767.96-29.76-39.5716.48-32.30
   EV/EBIT(x)767.96-29.76-39.5716.48-32.30
   EV/CE(x)1.110.810.840.761.93
   M Cap / Sales1.00
Growth Ratio
   Net Sales Growth(%)-100.00
   Core EBITDA Growth(%)105.35-22.73-121.62263.13-126.52
   EBIT Growth(%)105.35-22.73-121.62263.13-126.52
   PAT Growth(%)103.90-22.88-121.65262.91-126.15
   EPS Growth(%)104.07-22.78-121.66262.86-125.78
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.020.010.00
   Current Ratio(x)0.011.480.370.990.04
   Quick Ratio(x)0.011.480.370.990.04
   Interest Cover(x)39.00-486.00-1188.001374.00-1631.54
   Total Debt/Mcap(x)0.000.000.020.010.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.